10/26/2026 ValuEngine Weekly Market Commentary

Weekly Market Recap – Week Ending Oct 23, 2026 U.S. equity markets remained mixed this week, with weakness in growth-oriented sectors offset by continued strength in value, defensive, and energy-related stocks. The NASDAQ 100 ETF (QQQM) declined 0.75%, while the S&P 500 ETF (SPYM) was nearly flat, slipping just 0.04%. Communication Services (XLC) led the … Read more

ValuEngine Weekly: Basic Materials Stocks, Chemours Company,Valuation Watch, and More

This week, we provide top-five ranked VE data for our Basic Materials Sector stocks. We take a look at our latest data on Chemours Company $CC and provide a free download link for our stock report on the company. VALUATION WATCH: Overvalued stocks now make up 61.86% of our stocks assigned a valuation and 26.49% … Read more

ValuEngine Weekly: Medical Stocks, JPMorgan Chase, Valuation Watch, and More

This week, we provide top-five ranked VE data for our Medical Sector stocks. We take a look at our latest data on JPMorgan Chase $JPM and provide a free download link for our stock report on the company. Because overvaluation has crept up again, we now have another Valuation Watch. VALUATION WATCH: Overvalued stocks now … Read more

ValuEngine Weekly: Health Care Stocks, IBM, Valuation Watch, and More

This week, we provide top-five ranked VE data for our Health Care stocks. We take a look at our latest data on IBM $IBM. We currently have an overvaluation watch underway. VALUATION WATCH: Overvalued stocks now make up 61.45% of our stocks assigned a valuation and 25.36% of those equities are calculated to be overvalued … Read more